Research Admin Offices:

• ROADS

Opportunity Type:

• Grant

Value:

Dream of A Cure Summer Studentships in Inherited Bleeding Disorder Research Program: Support will be offered to interested Canadian medical or science students for up to 4 months for a maximum stipend of $6,000 per student.

CHS / Pfizer Care Until Cure Research Program: Grants for one to two years with a maximum of $75,000 per year will be awarded for clinical research, including outcome evaluation, in fields relevant to improving the health and the quality of life for persons with Hemophilia, persons with von Willebrand disease or other inherited bleeding disorders, persons with related conditions such as HIV or hepatitis C infection, and carriers of an inherited bleeding disorder.

CHS/Novo Nordisk Canada Psychosocial Research Program: The primary intent of this program is to offer one $20,000 research grant. Grants will be offered for a one-year period to begin in April 2024.

The Canadian Hemophilia Society – Bayer ADVANCE Canada Research Program: The primary intent of this program is to offer one or two $30,000 research grants, to a maximum of $60,000 for one year.

Disciplines:

• Faculty of Social Sciences

Sponsors:

• Canadian Hemophilia Society

Deadlines:

Additional Dates:

• ROADS NOI - October 27, 2023

Description:

Dream of A Cure Summer Studentships in Inherited Bleeding Disorder Research Program: The studentships are no longer limited to hemophilia-related projects but include all inherited bleeding disorders. Furthermore, science students in any year of an undergraduate program can apply in addition to medical students in any year of training. Through funds provided by the Hemophilia Research Million Dollar Club and the CHS, the CHS provides studentships aimed at developing treatments for hemophilia A and B, von Willebrand disease, rare factor deficiencies, platelet function disorders and ultimately, finding a cure.

CHS / Pfizer Care Until Cure Research Program: This program allows Canadian investigators to conduct research on medical and psychosocial aspects of bleeding disorders. The areas of interest to which investigators are encouraged to submit proposals has been expanded to include mild hemophilia A and B and Factor Utilization & Cost-effectiveness; Basic Science of TFPI & Anti-TFPI Monoclonal Antibodies section has been clarified and expanded; all projects included but not limited to the list will be considered.

CHS/Novo Nordisk Canada Psychosocial Research Program: The CHS/Novo Nordisk Canada Psychosocial Research Program was created to engage hemophilia program professionals/graduate students from the allied health disciplines (ie. Nursing, Physiotherapy & Social Work) in research activities addressed to understanding the psychosocial impact of hemophilia and other inherited bleeding disorders and to improve the quality of life of persons and families whose lives are affected by these disorders.

The Canadian Hemophilia Society – Bayer ADVANCE Canada Research Program: The Canadian Hemophilia Society – Bayer ADVANCE Canada Research Program was created to engage Canadian hemophilia treaters in activities to identify and research key issues in the ageing hemophilia population.

Resources:

Additional Details.

Contact:

For more information on how to apply, please contact Beatrice Fletcher, Senior Advisor, ROADS.